Program/
Therapeutic Area
Therapeutic Area
Target(s)
Format
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Commercialization Rights
INBRX-106
Oncology
Oncology
OX40
Multivalent Agonist

INBRX-111
Pseudomonas aeruginosa
Pseudomonas aeruginosa
PCRV,OPRI
Multi-functional Anti-infective

Program/
Therapeutic Area
Therapeutic Area
Target(s)
Format
Stage of Discovery
INBRX-106
Oncology
Oncology
OX40
Multivalent Agonist
Discovery
INBRX-111
Pseudomonas aeruginosa
Pseudomonas aeruginosa
PCRV,OPRI
Multi-functional Anti-infective
Discovery